fce 28260 has been researched along with enkephalin, leucine in 1 studies
| Studies (fce 28260) | Trials (fce 28260) | Recent Studies (post-2010) (fce 28260) | Studies (enkephalin, leucine) | Trials (enkephalin, leucine) | Recent Studies (post-2010) (enkephalin, leucine) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 11,524 | 80 | 754 |
| Protein | Taxonomy | fce 28260 (IC50) | enkephalin, leucine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0142 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0417 | |
| Mu-type opioid receptor | Homo sapiens (human) | 9.5 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0308 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.246 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meanwell, NA | 1 |
1 review(s) available for fce 28260 and enkephalin, leucine
| Article | Year |
|---|---|
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design.
Topics: Alkanes; Animals; Drug Design; Fluorine; Halogenation; Humans | 2018 |